DiscoveRx at SLAS2014: Integrating Target Biology & Phenotypic Screening

DiscoveRx offers both phenotypic and target-based drug discovery solutions! With the largest portfolio of target-based assay solutions PLUS the world’s largest collection of human primary cell systems for phenotypic drug discovery, DiscoveRx is Integrating Target Biology with Phenotypic Screening.

Visit DiscoverRx at Booth #1035 to learn how our integrated biological approach can accelerate your drug discovery programs!

• >45 BioMAP® human primary cell profiling systems
• 1000's of target-based assay solutions
• Meet with our drug discovery experts to discuss your screening challenges
• InCELL Hunter™ technology platform for measurement of target engagement in live cells
• Plus, enter to win a free assay-ready kit of your choice!
Visit the DiscoveRx SLAS2014 webpage by clicking on the company website link below for complete details.


Conference Event & Activity Schedule

Podium Presentation
Tuesday January 21, 10:30 am - 11:00 am
Predictive Models for Mechanism of Action Classification from Phenotypic Assay Data: Application to Phenotypic Drug Discovery
Speaker: Ellen L. Berg (BioMAP®/DiscoveRx)
Track: Informatics
Session: Title Extracting Meaning from Complex Data

Tutorial
Tuesday January 21, 2:00 pm - 2:45 pm Room 28C
InCELL Hunter™: A Novel Target Engagement Platform Enabling Direct Measurement of Compound Binding to Intracellular Targets in Intact Mammalian Cells
Speakers: Doug Auld, PhD (Novartis) & Jan Lamerdin, PhD (DiscoveRx)

DiscoveRx Scientific Posters
Monday, January 20, 1:00 pm – 3:00 pm
Detection of Cytokine and Growth Factor Receptor Dimerization using Enzyme Fragment Complementation (230)
Track Title Assay Development and Screening

Monday, January 20, 2014, 1:00 pm – 3:00 pm
Primary Human Cell Systems for Drug Discovery (180)
Track Title Assay Development and Screening

Tuesday, January 21, 2014, 1:00 pm – 3:00 pm
Detection of Endogenous Ligand Bias: A Case Study Using the Chemokine Receptor Family (261)
Track Title Assay Development and Screening

Tuesday, January 21, 2014, 1:00 pm – 3:00 pm
Dual Kinase/Bromodomain Inhibitors for Rationally Designed Polypharmacology (219)
Track Title Assay Development and Screening